| __timestamp | Ionis Pharmaceuticals, Inc. | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 79383000 |
| Thursday, January 1, 2015 | 37173000 | 108402000 |
| Friday, January 1, 2016 | 48616000 | 46928000 |
| Sunday, January 1, 2017 | 108488000 | 74959000 |
| Monday, January 1, 2018 | 244622000 | 79716000 |
| Tuesday, January 1, 2019 | 287000000 | 74669000 |
| Wednesday, January 1, 2020 | 354000000 | 59040000 |
| Friday, January 1, 2021 | 186000000 | 77417000 |
| Saturday, January 1, 2022 | 151000000 | 91473000 |
| Sunday, January 1, 2023 | 232600000 | 94314000 |
| Monday, January 1, 2024 | 267474000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing operational costs is crucial. Ionis Pharmaceuticals, Inc. and MannKind Corporation, two prominent players, have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Ionis Pharmaceuticals has seen a significant rise, with expenses peaking in 2020, marking a 1,650% increase from 2014. This surge reflects their aggressive expansion and investment in research and development. In contrast, MannKind Corporation's SG&A expenses have remained relatively stable, with a modest 19% increase over the same period. This stability suggests a more conservative approach to cost management. The data highlights the strategic differences between these companies, offering insights into their operational priorities and market strategies. As the biotech industry continues to evolve, understanding these financial trends is essential for investors and stakeholders.
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Axsome Therapeutics, Inc. and MannKind Corporation
Cost Management Insights: SG&A Expenses for CymaBay Therapeutics, Inc. and MannKind Corporation
Comparing SG&A Expenses: Viking Therapeutics, Inc. vs MannKind Corporation Trends and Insights
MannKind Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
MannKind Corporation and Dynavax Technologies Corporation: SG&A Spending Patterns Compared